• Strategy
  • Innovation
  • Expertise

Agreement to acquire AstraZeneca Insurance Company Limited

23 December, 2016

Randall & Quilter Investment Holdings Ltd (‘R&Q’ or ‘the Group’) is pleased to announce that it has signed an agreement to acquire, subject to a pre-completion capital restructuring and to change of control approval from each of the PRA and FCA, the entire issued share capital of AstraZeneca Insurance Company Limited (‘AZICO’) (‘the Company’) from its owners AstraZeneca UK Limited. AZICO was formed in 1994 as the UK registered captive insurer for AstraZeneca. It ceased active underwriting in 2004. The pre-completion capital restructuring is expected to take place within the same timeframe as the regulatory approval process.

The residual liabilities comprise primarily of UK Employers’ Liability. AZICO had gross claim reserves as at 31st December 2015 amounting to £15.7m. The consideration payable by R&Q, in cash from existing resources and its bank facility with RBS, will depend on the outcome of the capital restructuring but will be between £10.2m to £34.6m. This represents a small discount to the Company’s anticipated post-capital restructuring net assets of £12.9m to £37.9m. In the year to 31st December 2015 no profit or loss was attributable to the assets of the acquisition.

The Company will be managed by R&Q with the intention of undertaking a Part VII Transfer of the remaining insurance business to one of the Group’s consolidation vehicles, subject to the usual regulatory and Court approvals, in due course.

Commenting on today’s announcement, Ken Randall, Chairman and Chief Executive Officer of Randall & Quilter, said:

“We are pleased to have entered into an agreement to acquire AZICO from AstraZeneca UK Limited.

This is the second transaction that we have concluded with AstraZeneca to assist them exiting their captive insurance companies in run-off and further demonstrates the attractions of the Group’s offerings to major corporations.”

Click here for the full Press Release

Agreement to acquire AstraZeneca Insurance Company Limited

Latest News

Appointment of Broker
Appointment of Broker

Randall & Quilter Investment Holdings Ltd. (“Randall & Quilter”) today announces the appointment of Barclays Bank PLC (“Barclays”) as its joint corporate broker with immediate effect. Barclays will work alongside Randall & Quilter’s existing corporate broker and nominated adviser, Numis …

Director/PDMR Shareholding
Director/PDMR Shareholding

The Company has been notified that on 6 January 2021 Alan Quilter, the Chief Executive Officer of the Company, sold his interest in 400,000 ordinary shares in the Company. Mr Quilter continues to hold 2,078,091 ordinary shares which represents 0.93% …

Regulatory Approval of UK Legacy Acquisitions
Regulatory Approval of UK Legacy Acquisitions

Further to its announcements on 19 August 2020 and 21 August 2020, Randall & Quilter Investment Holdings Ltd. (“R&Q”), is pleased to announce that its wholly owned UK subsidiary, Randall & Quilter II Holdings Limited, has received regulatory approval and …